Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bayliss

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
The Patient|August 16, 2017
Light Chain (AL) Amyloidosis: The Journey to DiagnosisKristen L McCausland, Michelle K White, Spencer D Guthrie, et al.
Journal of Patient-Reported Outcomes|May 15, 2018
Content validation of the SF-36v2® health survey with AL amyloidosis patientsMichelle K White, Martha S Bayliss, Spencer D Guthrie, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 12, 2018
Humanistic burden of disease for patients with advanced melanoma in CanadaWinson Y Cheung, Martha S Bayliss, Michelle K White, et al.
Health Technology Assessment (Winchester, England)|February 7, 2007
Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluationY Adi, A Juarez-Garcia, D Wang, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 24, 2018
Patient-reported treatment-related symptom burden for patients with advanced melanoma in CanadaWinson Y Cheung, Michelle K White, Martha S Bayliss, et al.
American Health & Drug Benefits|January 17, 2019
Treatment Tolerability in Patients with Immunoglobulin Light-Chain AmyloidosisAvery A Rizio, Michelle K White, Kristen L McCausland, et al.
NPJ Primary Care Respiratory Medicine|November 25, 2018
Systematic review of the effectiveness of community-based self-management interventions among primary care COPD patientsK Jolly, M S Sidhu, E Bates, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 4, 2003
Applications of computerized adaptive testing (CAT) to the assessment of headache impactJohn E Ware, Mark Kosinski, Jakob B Bjorner, et al.
Journal of Hepatology|February 24, 2001
The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivityJ G McHutchison, J E Ware, M S Bayliss, et al.
Health Technology Assessment (Winchester, England)|December 13, 2005
The effectiveness and cost-effectiveness of parent training/education programmes for the treatment of conduct disorder, including oppositional defiant disorder, in childrenJ Dretzke, E Frew, C Davenport, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
The Patient|August 16, 2017
Light Chain (AL) Amyloidosis: The Journey to DiagnosisKristen L McCausland, Michelle K White, Spencer D Guthrie, et al.
Journal of Patient-Reported Outcomes|May 15, 2018
Content validation of the SF-36v2® health survey with AL amyloidosis patientsMichelle K White, Martha S Bayliss, Spencer D Guthrie, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 12, 2018
Humanistic burden of disease for patients with advanced melanoma in CanadaWinson Y Cheung, Martha S Bayliss, Michelle K White, et al.
Health Technology Assessment (Winchester, England)|February 7, 2007
Oral naltrexone as a treatment for relapse prevention in formerly opioid-dependent drug users: a systematic review and economic evaluationY Adi, A Juarez-Garcia, D Wang, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 24, 2018
Patient-reported treatment-related symptom burden for patients with advanced melanoma in CanadaWinson Y Cheung, Michelle K White, Martha S Bayliss, et al.
American Health & Drug Benefits|January 17, 2019
Treatment Tolerability in Patients with Immunoglobulin Light-Chain AmyloidosisAvery A Rizio, Michelle K White, Kristen L McCausland, et al.
NPJ Primary Care Respiratory Medicine|November 25, 2018
Systematic review of the effectiveness of community-based self-management interventions among primary care COPD patientsK Jolly, M S Sidhu, E Bates, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 4, 2003
Applications of computerized adaptive testing (CAT) to the assessment of headache impactJohn E Ware, Mark Kosinski, Jakob B Bjorner, et al.
Journal of Hepatology|February 24, 2001
The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivityJ G McHutchison, J E Ware, M S Bayliss, et al.
Health Technology Assessment (Winchester, England)|December 13, 2005
The effectiveness and cost-effectiveness of parent training/education programmes for the treatment of conduct disorder, including oppositional defiant disorder, in childrenJ Dretzke, E Frew, C Davenport, et al.
Pageof 6